Reynolds CP - Search Results

1

MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.

Wei SJ, Nguyen TH, Yang IH, Mook DG, Makena MR, Verlekar D, Hindle A, Martinez GM, Yang S, Shimada H, Reynolds CP, Kang MH. Wei SJ, et al. Among authors: reynolds cp. Cell Death Dis. 2020 May 14;11(5):368. doi: 10.1038/s41419-020-2563-4. Cell Death Dis. 2020. PMID: 32409685 Free PMC article.

2

Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.

Makena MR, Cho HE, Nguyen TH, Koneru B, Verlekar DU, Hindle A, Kang MH, Reynolds CP. Makena MR, et al. Among authors: reynolds cp. Pediatr Blood Cancer. 2018 Dec;65(12):e27447. doi: 10.1002/pbc.27447. Epub 2018 Sep 24. Pediatr Blood Cancer. 2018. PMID: 30251395 Free PMC article.

3

Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.

Nguyen TH, Koneru B, Wei SJ, Chen WH, Makena MR, Urias E, Kang MH, Reynolds CP. Nguyen TH, et al. Among authors: reynolds cp. Mol Cancer Ther. 2019 Dec;18(12):2270-2282. doi: 10.1158/1535-7163.MCT-19-0385. Epub 2019 Sep 4. Mol Cancer Ther. 2019. PMID: 31484706 Free PMC article.

4

Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.

Sonawane P, Cho HE, Tagde A, Verlekar D, Yu AL, Reynolds CP, Kang MH. Sonawane P, et al. Among authors: reynolds cp. Br J Pharmacol. 2014 Dec;171(23):5330-44. doi: 10.1111/bph.12846. Br J Pharmacol. 2014. PMID: 25039756 Free PMC article. Clinical Trial.

5

Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.

Kang MH, Wang J, Makena MR, Lee JS, Paz N, Hall CP, Song MM, Calderon RI, Cruz RE, Hindle A, Ko W, Fitzgerald JB, Drummond DC, Triche TJ, Reynolds CP. Kang MH, et al. Among authors: reynolds cp. Clin Cancer Res. 2015 Mar 1;21(5):1139-50. doi: 10.1158/1078-0432.CCR-14-1882. Clin Cancer Res. 2015. PMID: 25733708

6

Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.

Hall CP, Reynolds CP, Kang MH. Hall CP, et al. Among authors: reynolds cp. Clin Cancer Res. 2016 Feb 1;22(3):621-32. doi: 10.1158/1078-0432.CCR-15-0114. Epub 2015 Jun 16. Clin Cancer Res. 2016. PMID: 26080839 Free PMC article.

7

Reactive Oxygen Species-Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies.

Makena MR, Koneru B, Nguyen TH, Kang MH, Reynolds CP. Makena MR, et al. Among authors: reynolds cp. Mol Cancer Ther. 2017 Apr;16(4):649-661. doi: 10.1158/1535-7163.MCT-16-0749. Epub 2017 Jan 23. Mol Cancer Ther. 2017. PMID: 28119491

8

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.

Koneru B, Lopez G, Farooqi A, Conkrite KL, Nguyen TH, Macha SJ, Modi A, Rokita JL, Urias E, Hindle A, Davidson H, Mccoy K, Nance J, Yazdani V, Irwin MS, Yang S, Wheeler DA, Maris JM, Diskin SJ, Reynolds CP. Koneru B, et al. Among authors: reynolds cp. Cancer Res. 2020 Jun 15;80(12):2663-2675. doi: 10.1158/0008-5472.CAN-19-3068. Epub 2020 Apr 14. Cancer Res. 2020. PMID: 32291317 Free PMC article.

9

ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.

Koneru B, Farooqi A, Nguyen TH, Chen WH, Hindle A, Eslinger C, Makena MR, Burrow TA, Wilson J, Smith A, Pilla Reddy V, Cadogan E, Durant ST, Reynolds CP. Koneru B, et al. Among authors: reynolds cp. Sci Transl Med. 2021 Aug 18;13(607):eabd5750. doi: 10.1126/scitranslmed.abd5750. Sci Transl Med. 2021. PMID: 34408079 Free PMC article.

10

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.

Song MM, Makena MR, Hindle A, Koneru B, Nguyen TH, Verlekar DU, Cho H, Maurer BJ, Kang MH, Reynolds CP. Song MM, et al. Among authors: reynolds cp. Anticancer Drugs. 2019 Feb;30(2):117-127. doi: 10.1097/CAD.0000000000000696. Anticancer Drugs. 2019. PMID: 30272587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page